Subject Index

A 68930 130 appetitive Conditions 81 A 86929 130 arachidonic acid 185,223 acetylcholine (ACh) 9 arcuate nucleus 89,97 acoustic neurinoma 227 36 ACTH, see Adrenocortcotropic asynaptic release 100 hormone 173 ATF1, see Activating transcription factor activating transcription factor 1 (ATF 1) 1 326 attention 276 adaptive reponses 321 attention deficit hyperactivity disorder adenosine A2A receptor 164 (ADHD) 278 adenosine triphosphatase 269, 306 autism 128 adenylyl cyclase 11, 121, 163, 185, 236 autoreceptor 34 ADHD, see attention deficit aversive conditions 81 hyperactivity disorder adrenal gland 173 basal ganglia 31,166,310 adrenal medullary hormones 25 bed nucleus 55 adrenocorticotropic hormone (ACTH) benzazepine 130, 140 173 benzonaphtazepine 131 aggression 276 benztropine 270 akinesia 167 beta (~) adrenoreceptor 10, 238 alcohol 33, 169,203 beta (~)-arrestin 135 alpha (a)olf protein 237 beta (~)-endorphin 173 alpha (a)receptor adrenergic 10 biogenic amines 29 alpha's protein 237 bipolar cell 92 alpha-(a) melanocyte stimulating bipolar disorder 127,227 hormone (a-MSH) 171 bradykinesia 167 alpha-(a) methyltyrosine 33 brain development 201 amacrine cells 92 brain-derived neurotrophic factor amineptine 206 (BDNF) 187 aminotetralin 195 12, 171, 309 196 brown adipose tissue 243 206 buproprion 206 AMPA receptor channels 333 125,131 amperozide 196 amphetamine 12,33,135, 169,270,276, calbindin (CaBP) 44,87 325 calcineurin 244 amphetamine stereoselectivity 262 calcium channels 302 amygdala 55, 81, 137 calcium chela tors 303 antidepressant drugs 206 calcium-binding protein, see calbindin treatment 199 87 antisense oligonucleotides 143 calmodulin 239 antisense-treatment 277 calretinin 87 12, 35 cAMP-dependent kinase 186 340 Subject Index

cAMP-response element binding protein dentate gyrus 52 (CREB) 163,241 desipramine 207,257,264 196 dextran amine, biotinylated 65 Catalase 170 diagonal band nuclei 79 caudate neuron activity 9 130,141 caudate nucleus 5,68 beta (B)-3,4-dihydroxyphenylethylamine central (amygdala) nucleus 55 2 cerebellar peduncle, superior 44 3,4-dihydroxyphenylserine (DOPS) 4 c-fos 191, 325 diphenylpiperazine 257 24,30,196,223 dopa decarboxylase 2, 23 cholera toxin 133 dopa decarboxylase inhibitors 5 cholezystokinin 189 axons 67 choline 268 - transmitting elements 96 choline acetyltransferase 73 dopamine de nervation 312 choroid plexus 243 dopamine neurons ultrastructure chromaffin cells 243 63 clathrin 275 dopamine pathway, nigrostriatal 6 33,196,223,228,327 dopamine projection gradient 46 cocaine 30,169,197,203,257,325 activation 301 cocaine antagonists 262, 273 dopamine receptor agonist 34 cognition 43 dopamine receptor antagonist 34 concanavalin A 135 dopamine receptor concept 11 cortex, temporal 85 dopamine signal transduction 238 cortical afferents 78 dopamine transmission 64, 103 cortical areas, sensory 84 dopamine transporter (DAT) 66, 76 cortico-ventrotriatal circuits 199 - topology 259 COS-7 cells 223 - gene 263 CREB, see cAMP-response element - immunoreactivity 266 binding protein - polymorphism 280 Cushing's syndrome 173 - expression 89 cyclic adenosine monophosphate dopamine uptake inhibitors 206, 272, (cAMP) 132,322 275 dopamine varicosities 67 DI (Dopamine!) receptor 12,74,121, dopamine, 321 - vasopressor action DI (dopamine I) receptor - regional distribution 26 - labelling 75 dopamine-beta(~)-hydroxylase (DBH) - distribution 88 66 - molecular cloning 121 dorsal tier 46 - point mutations 124 drug addiction 299 - truncation 125 dynamine 135 Die (dopamined receptor 145 dynorphin 187,204,326 D2 (dopaminez) receptor 12,35,74 - agonists 308 electroconvulsive shocks 207 - knockout 165 emonapride 227 D3 (dopamine3) receptor 78 endocrine tumors 161 - coupling 186 enkephalin 72,169,302,327 - overexpression 194 epileptic seizures 171 D4 (dopamine4) receptor epinephrine 223 - gene 225 ergot alkaloids 12 - labelling 89 ethanol, see alcohol Ds (dopamines) receptor 74 excitatory postsynaptic potential (EPSP) DARPP-32 242 304 DARPP-32 phosphorylation 244 excitatory synaptic input 305 densocellular area 52 exocytosis 30, 100 densocellular group 47 extrapyramidal side effects 34 Subject Index 341

fiber degeneration 54 incerto-hypothalamic system 89 fibroblasts 186 indolophenanthridine 130 fiuoxetine 206 inducible CRE repressor (ICER) forebrain 43 326 forskolin 186 intercalated cell groups 81 interneurons, cortical 87 G protein 101,322 intervaricose segments 70 G protein activation 134 intrinsic membrane conductance 306 G protein coupled receptors (GPCR) inwardly rectifying K+ (IRK) channels 122, 161 303 gamma-(y)aminobutyric acid (GABA) ionic conductance 304 11,68,167,300 ischemia 170 gamma-(y)aminobutyric acid (GABA) A islands of Calleja 187 receptors 304 isochroman 130 gamma-(y)aminobutyric acid (GABA) isoquinoline 131,140 dendrites 86 gene expression 99 lun N-terminal kinase (JNK) 329 glia 87 globus pallidus 79,166 K+ channels 163 glutamate 9,54 kainic acid 171 glutamate receptor 245 Kir2 channels 301 glutamate receptor subunit 2 (Glu R2) 333 lactotroph cells 161 glutamate terminals 72 L-Dopa 5,27,142,174,193 glutamate transmission 82 learning 43,276,309 glutaraldehyde 64 levodopa, see L-Dopa glutathioine 170 light-dark adaptation 92, 99 golgi impregnation subtypes 74 limbic areas, forebrain 6 grooming 139 limbic brain 54, 185 growth hormone-releasing hormone limbic cortex 6 172 309 GTP-binding protein 162, 236 lithium 268 local circuit neurons 102 hallucinations 175 locomotion 140 32, 196,223, 307 locus ceruleus 91 heart 225 lordosis behaviour 143 heroin 203 Ltk cells 136 hippocampus, dentate gyrus 137 luteinizing hormone-releasing hormone histofiuorescence method 6 (LH-RH) 90 homovanillic acid 10 LY 270411 131 Huntington's chorea 26,36,127,170 lysergic acid diethylamide (LSD) 24 hydrogen peroxide 170 5-hydroxydopamine 64 magnesium block 305 6-hydroxydopamine 7,65,167,192,203, mania 206, 281 278 mazindol 257, 270 D,L-5-hydroxytryptophan 3 median eminence 90, 97 5-hydroxytryptophan 26 medium spiny neurons 300 3-hydroxytyramine 2 melanotroph cells 161 hyperiocomotion 277 membrane presentation 159 hypermotility 276 memory 276,309 hypodopaminergia 36 mesencephalon 265 hypothalamus 265 mesocortical projection 83 mesocorticolimbic pathway 176 196 metamphetamine 170, 279 30, 207 methadone 14 immunogold labeling method 75,267 3-methoxytyramine 32 342 Subject Index

I-methyl-4-phenyl-l,2,3,6- nucleus basalis of Meynert 79 tetrahydropyridine (MPTP) 7, 36, nucleus ruber 44 142,192,257 I-methyl-4-phenylpyridinium (MPP+) 223,334 260 olfactory neurons 246 olfactory tubercle 6,77,137,264 Michaelis-Menten-equation 269 open field test 168 midbrain tegmentum 6 opiates 33, 169 mitochondria 100 opioid peptides 97 mitogen-activated protein 192 osmium tetroxide 64 mitogen-activated protein kinase oxidative stress 171 (MAPK) 163, 246, 322 oxytocin 91 mitogenesis 186 monoamine axons 100 pain 98 monoamine cortical systems 84 pallidum, ventral 79 monoamine oxidase (MAO) inhibitor para brachial pigmented nuclei 43 30 paranigral nucleus 43 monoamine oxidase B 8, 170, 279 parathyroid hormone 235 morphine 14 para ventricular nucleus 91 motivation 43 Parkinsonism, reserpin induced 4, 26 motor activity 276 Parkinsonism, postencephalitic 31 motor control 43 Parkinson's disease 104,142,159,170, motor function 98, 166 267,281,299 motor memory 310 - unilateral 10 motor regions 53 parvalbumin 87 MPP+ 8 pathways, nigrostriatal 44 multiple system atrophy 273 pathways, striatonigral 44 myoclonic jerking 139 pertussis toxin 133 phenoxybenzamine 32 nafadotride 193 phenylethanolamnie neocortex 137 N-methyltransferase (PNMT) 81 neostriatum 299,308 phosphatidylinositol 322 neurabin 1 241 phosphoinositide (PI) 145 neuromelanin 44 phospholipase A2 163,310 neuropeptide Y 73 phospholipase C (PLC) 238 neuropil 87 photoreceptor 95 neurosurgery, functional 9 196,275 neurotensin 78,82,187,329 196 neurotensin gene transcripts 199 pituitary (gland) 90, 171, 225 nicotinamide adenine dinucleotide pituitary hormones 98 phosphate (NADPH) 73 pituitary tumors 159, 172 nicotine 205 pituitary, anterior 6 nigrostriatal pathway 6, 176 plexiform layer 93 N-methyl-D-aspartate 240 PNMT antibodies 82 nociception 97 POU transcription factor 122 nomifensine 206,257,270 3-PPP 34 noradrenaline (NA) 8,209,223 210 noradrenaline transporter (NET) 258 premotor regions 53 norepinephrine (NE) fibers 64 196 norepinephrine (NE), see Noradrenaline progesterone 171 normethanephrine 32 progressive supranuclear palsy 273 northern analysis 265 projection system, striato-nigro-striatal nuclease protection assay 265 50 nucleus accumbens 6,50,65,68,79, projection, central striatum 49 136,187,264 projection, striatonigral 48 - shell 79 projections, corticostriatal 52 Subject Index 343

projections, corticothalamic 52 somatostatin 82 prolactin 171 somatostatin receptor 164 prolactinoma 172 spectrophotofluorimeter 24 proopiomelanocortin (POMC) 172 spinal cord 98 protein kinase A 136,239,322 spinophilin 241 protein phosphatase 1 (PP1) 241 spiny dendrites 72 projection, dorsolateral striatal 48 223 pseudo-rabies-virus 86 stabilizers, 36 psychosis 173 stathmin 240 psychostimulants 201 stochastic resonance 103 psychotic reaction 13 stress 209 puncta adherentia 102 stress-activated protein (SAP) kinase putamen 5, 68 329 pyramidal neurons 85 stria terminalis 55 stria terminalis 142,275 - bed nucleus 79 - septal complex 80 196,223,227,275 striatal region receptor surface, intracellular 132 - cognitive 52 receptors, presynaptic 34 -limbic 52 red nucleus 44 - motor 52 196,223 striatonigral fibers, ventromedial 49 reserpine 24,167,309 striatum 44,102,264 reserpine syndrom 4 striatum, dorsolateral 50 retina 137,225 striatum, functional regions 45 retinitis pigmentosa 202 striatum, ventral 34 retinoic acid responsive element 160 striatum, ventromedial shell 45 retinoid X receptor 161 striatum, ventromedial 50 retrorubral cell groups 43 subiculum 52 reward 33,43 substance P 72,169,187,204,302 rhinal cortex 83 substantia innominata 79 ring test 168 substantia nigra, pars compacta (SNC) 196,223,334 43 RNA polymerase II complex 323 - dorsal group 44 rotarod apparatus 167 - densocellular region 44 - cell columns 44 SCH 23390 130, 136 subthalamic nucleus 167 SCH 23892 136 sucrose 268 schizophrenia 14,35,127,159,173,227, 196,223 281 196 semiquinone 170 superoxide dismutase 170 sensorimotor gating 200 suprarhinal area 83 septal nucleus 55 synapses, axo-axonic 85 serine 223 synapses, axodendritic 70, 81 serotonin 209 synapses, axosomatic 81,85 serotonin N-acetyltransferase 225 synapses, axospinous 68, 70 196 synapses, symmetric 68 seven transmembrane domain (7TM) synaptic incidence 84 161 synaptic plasticity 310 sexual behaviour 276 synaptic transmission 304, 307 signal detection 88 synaptic vesicle proteins 323 signal transduction cascades 323 synaptic vesicles 29 SK & F 89145 130 synaptology, specific differences 77 SK & F 89615 130 SKF 38393 129 tanycytes 90,243 sniffing 140 tardive dyskinesia 334 344 Subject Index testosterone 171 tyramine 269 tetrodotoxin 245 hydroxylase (TH) 65,267 thalamus 72, 166 tyrosine kinase 223 thienoazepine 140 thienopyridine 130 Ungerstedt's rotation model 193 thiophenanthrene 130 196 vacuous chewing 140 threonine 223 vasoactive intestinal peptide (VIP) 172, thyroid hormone 161 240 thyrotropin releasing hormone (TRH) ventral peri ventricular nucleus 89 172 ventral striatum 76 Tourette's syndrome 127,159,227,273, ventral tegmental area (VTA) 43,67, 299 266 transcription factor 323 ventral tier 46 transcription initiation site 323 vitamin D3 receptor 160 transcriptional regulation 159 vitamin E 170 transmission, cholinergic 73 voltage-clamp studies 301,312 tranylcypromine 207 voltage-clamp studies 312 tuberoinfundibular pathway 89,176, 265 zona incerta 265